When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XLRN - Acceleron's sotatercept nabs accelerated review for type of high blood pressure
Acceleron Pharma Inc.
The FDA designates Acceleron Pharma's (NASDAQ:XLRN) sotatercept Breakthrough Therapy for the treatment of pulmonary arterial hypertension (PAH), a type of high blood pressure affecting the heart and lungs.
More news on: Acceleron Pharma Inc., Healthcare stocks news,